Showing results (11-20 of 83) with videos related to
Sort By:
Pageof 9
Current Cancer Drug Targets|May 14, 2015
Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate CancerLewis Quayle, Penelope D Ottewell, Ingunn HolenEuropean Journal of Haematology|March 25, 2010
Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cellsMichiyo Kobayashi-Sakamoto, Emiko Isogai, Ingunn HolenExpert Review of Molecular Diagnostics|February 10, 2018
The breast tumor microenvironment: role in cancer development, progression and response to therapySuruchi Mittal, Nicola J Brown, Ingunn HolenBonekey Reports|April 8, 2015
Molecular alterations that drive breast cancer metastasis to bonePenelope D Ottewell, Liam O'Donnell, Ingunn HolenBonekey Reports|May 6, 2014
Targeting RANKL in metastasisWilliam C Dougall, Ingunn Holen, Eva González SuárezClinical & Experimental Metastasis|November 1, 2018
Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retentionLewis A Quayle, Penelope D Ottewell, Ingunn HolenDisease Models & Mechanisms|April 7, 2017
<i>In vivo</i> models in breast cancer research: progress, challenges and future directionsIngunn Holen, Valerie Speirs, Bethny Morrissey, et al.The Proceedings of the Nutrition Society|December 12, 2022
The Second Nutrition and Cancer Networking Meeting Nutrition and Breast Cancer: Translating Evidence into PracticeJames L Thorne, Ingunn Holen, Bernard M CorfeMolecular Cancer|July 17, 2009
Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contactPenny E Reid, Nicola J Brown, Ingunn HolenAnti-Cancer Drugs|December 23, 2004
Preclinical evidence for the effect of bisphosphonates and cytotoxic drugs on tumor cell invasionJulia K L Woodward, Robert E Coleman, Ingunn HolenPageof 9